About hexasilver;tetrakis(2-(5-methylpyrazol-2-id-3-yl)-6-(5-methyl-1H-pyrazol-3-yl)pyridine);propan-2-one;dinitrate
hexasilver;tetrakis(2-(5-methylpyrazol-2-id-3-yl)-6-(5-methyl-1H-pyrazol-3-yl)pyridine);propan-2-one;dinitrate (PubChem CID 139150447) has the molecular formula C55H54Ag6N22O7
and a molecular weight of 1782.39 g/mol. Its IUPAC name is hexasilver;tetrakis(2-(5-methylpyrazol-2-id-3-yl)-6-(5-methyl-1H-pyrazol-3-yl)pyridine);propan-2-one;dinitrate.
Molecular Properties
| Compound Name | hexasilver;tetrakis(2-(5-methylpyrazol-2-id-3-yl)-6-(5-methyl-1H-pyrazol-3-yl)pyridine);propan-2-one;dinitrate |
| PubChem CID | 139150447 |
| Molecular Formula | C55H54Ag6N22O7 |
| Molecular Weight | 1782.39 g/mol |
| Exact Mass | 1775.89 |
| IUPAC Name | hexasilver;tetrakis(2-(5-methylpyrazol-2-id-3-yl)-6-(5-methyl-1H-pyrazol-3-yl)pyridine);propan-2-one;dinitrate |
| SMILES | CC(C)=O.Cc1cc(-c2cccc(-c3cc(C)[nH]n3)n2)[n-]n1.Cc1cc(-c2cccc(-c3cc(C)[nH]n3)n2)[n-]n1.Cc1cc(-c2cccc(-c3cc(C)[nH]n3)n2)[n-]n1.Cc1cc(-c2cccc(-c3cc(C)[nH]n3)n2)[n-]n1.O=[N+]([O-])[O-].O=[N+]([O-])[O-].[Ag+].[Ag+].[Ag+].[Ag+].[Ag+].[Ag+] |
| InChI | InChI=1S/4C13H12N5.C3H6O.6Ag.2NO3/c4*1-8-6-12(17-15-8)10-4-3-5-11(14-10)13-7-9(2)16-18-13;1-3(2)4;;;;;;;2*2-1(3)4/h4*3-7H,1-2H3,(H-,15,16,17,18);1-2H3;;;;;;;;/q4*-1;;6*+1;2*-1 |
| InChIKey | SHMNNMRYIKEKLL-UHFFFAOYSA-N |
| XLogP | 8.53 |
| TPSA | 423.71 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 19 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 90 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
| MW ≤ 500 | 1782.39 |
| LogP ≤ 5 | 8.53 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 19 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Analyze hexasilver;tetrakis(2-(5-methylpyrazol-2-id-3-yl)-6-(5-methyl-1H-pyrazol-3-yl)pyridine);propan-2-one;dinitrate with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of hexasilver;tetrakis(2-(5-methylpyrazol-2-id-3-yl)-6-(5-methyl-1H-pyrazol-3-yl)pyridine);propan-2-one;dinitrate?
The IUPAC name of hexasilver;tetrakis(2-(5-methylpyrazol-2-id-3-yl)-6-(5-methyl-1H-pyrazol-3-yl)pyridine);propan-2-one;dinitrate (CID 139150447) is hexasilver;tetrakis(2-(5-methylpyrazol-2-id-3-yl)-6-(5-methyl-1H-pyrazol-3-yl)pyridine);propan-2-one;dinitrate.
What is the SMILES notation for hexasilver;tetrakis(2-(5-methylpyrazol-2-id-3-yl)-6-(5-methyl-1H-pyrazol-3-yl)pyridine);propan-2-one;dinitrate?
The canonical SMILES for hexasilver;tetrakis(2-(5-methylpyrazol-2-id-3-yl)-6-(5-methyl-1H-pyrazol-3-yl)pyridine);propan-2-one;dinitrate is CC(C)=O.Cc1cc(-c2cccc(-c3cc(C)[nH]n3)n2)[n-]n1.Cc1cc(-c2cccc(-c3cc(C)[nH]n3)n2)[n-]n1.Cc1cc(-c2cccc(-c3cc(C)[nH]n3)n2)[n-]n1.Cc1cc(-c2cccc(-c3cc(C)[nH]n3)n2)[n-]n1.O=[N+]([O-])[O-].O=[N+]([O-])[O-].[Ag+].[Ag+].[Ag+].[Ag+].[Ag+].[Ag+].
What is the InChIKey of hexasilver;tetrakis(2-(5-methylpyrazol-2-id-3-yl)-6-(5-methyl-1H-pyrazol-3-yl)pyridine);propan-2-one;dinitrate?
The InChIKey is SHMNNMRYIKEKLL-UHFFFAOYSA-N. The full InChI is InChI=1S/4C13H12N5.C3H6O.6Ag.2NO3/c4*1-8-6-12(17-15-8)10-4-3-5-11(14-10)13-7-9(2)16-18-13;1-3(2)4;;;;;;;2*2-1(3)4/h4*3-7H,1-2H3,(H-,15,16,17,18);1-2H3;;;;;;;;/q4*-1;;6*+1;2*-1.
What are the key properties of hexasilver;tetrakis(2-(5-methylpyrazol-2-id-3-yl)-6-(5-methyl-1H-pyrazol-3-yl)pyridine);propan-2-one;dinitrate?
hexasilver;tetrakis(2-(5-methylpyrazol-2-id-3-yl)-6-(5-methyl-1H-pyrazol-3-yl)pyridine);propan-2-one;dinitrate has a molecular weight of 1782.39 g/mol, XLogP of 8.53, 8 rotatable bonds, 4 hydrogen bond donors, and 19 hydrogen bond acceptors.
Where does this data come from?
All data for hexasilver;tetrakis(2-(5-methylpyrazol-2-id-3-yl)-6-(5-methyl-1H-pyrazol-3-yl)pyridine);propan-2-one;dinitrate is sourced from PubChem (CID 139150447), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).